ARCHIVES

NCI Director Andrew von Eschenbach To Resign June 10, Remain As FDA Acting Commissioner.

This article is from The Cancer Letter archive.

Vol. 32 No. 21 | June 2, 2006

Download PDF Visit The Full Archive

Related Articles

James Abbruzzese Moves to Duke Cancer Institute

September 27, 2013

NCI AIDS Malignancy Bank Accepts Requests; RFA Available

December 1, 1995

Better Access Key To Higher Survival For African-Americans With Colon Cancer

August 30, 2002

NIH Panel Calls for Further Research On End-of-Life Issues.

January 21, 2005

NIEHS, Five Grantees Form Toxicogenomics Group.

November 16, 2001

ORI Finds Misconduct By Two Researchers

December 8, 1995